Medicare billing address
CMS Medicare provider billing file
100 E Lancaster AveJd Lankenau Pavilion, Mezzanine
Wynnewood, PA 19096
CMS public data · NPI 1528059763
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Kar Lai Wong, M.D.
Specialty
Credential
M.D.
NPI
1528059763
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Kar Lai Wong, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
100 E Lancaster AveCMS Doctors & Clinicians file
100 E Lancaster AveIn the 2024 CMS provider billing file, this NPI had 2,695 Medicare beneficiaries and 6,373 total services. The average beneficiary age was 77, and the average HCC risk score was 2.
Total Medicare allowed amount
$247,900.33
Total Medicare payment amount
$181,755.09
Medicare beneficiaries
2,695
Total services
6,373
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Ischemic heart disease
56%
CMS beneficiary-panel share
Atrial fibrillation
49%
CMS beneficiary-panel share
Heart failure
45%
CMS beneficiary-panel share
Chronic kidney disease
40%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 3,273 | $8.13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 764 | $14.61 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 563 | $130.93 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 384 | $29.57 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 350 | $26.11 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 169 | $36.70 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 157 | $79.57 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 126 | $22.97 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 112 | $132.13 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 66 | $171.58 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1528059763. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Metoprolol Succinate | Metoprolol Succinate | 1,177 | 2,839 | $17,691.84 |
| 2 | Eliquis | Apixaban | 834 | 1,614.9 | $943,570.19 |
| 3 | Xarelto | Rivaroxaban | 467 | 925 | $512,902.54 |
| 4 | Atorvastatin Calcium | Atorvastatin Calcium | 422 | 1,057.2 | $4,458.49 |
| 5 | Amiodarone Hcl | Amiodarone Hcl | 363 | 926.2 | $11,408.59 |
| 6 | Losartan Potassium | Losartan Potassium | 338 | 843.9 | $3,372.20 |
| 7 | Flecainide Acetate | Flecainide Acetate | 326 | 758.8 | $12,852.98 |
| 8 | Amlodipine Besylate | Amlodipine Besylate | 287 | 707 | $1,694.49 |
| 9 | Diltiazem 24Hr Er (Cd) | Diltiazem Hcl | 198 | 474 | $6,383.38 |
| 10 | Dofetilide | Dofetilide | 195 | 495.8 | $53,334.04 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Perelman School Of Med At The University Of Pennsylvania
Graduation year
1992
Group/practice field
Main Line Healthcare
Telehealth reported
Not reported
Secondary specialty fields reported by CMS: Cardiovascular Disease (Cardiology).
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.